Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2 **
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2 ** ; year:2020
ChemBioChem ; (2020)
- Creator
- DOI
-
10.1002/cbic.202000730
- URN
-
urn:nbn:de:101:1-2021020412584302550645
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schmalohr, Benjamin Franz
- Mustafa, Al‐Hassan M.
- Krämer, Oliver Holger
- Imhof, Diana
Other Objects (12)
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
Second-generation inhibitors of Bruton tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
Second-generation inhibitors of Bruton tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Histidine and Tyrosine-based Heme-binding Motifs for the Prediction of Heme-Regulated Proteins
Editorial: Targeting bruton tyrosine kinase
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance
Newer Tyrosine Kinase Inhibitors for CML
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
Second-generation inhibitors of Bruton tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mechanism of arsenite-induced activation of heme-regulated inhibitor kinase